Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Retrospective Multi-Institutional Study

BACKGROUND: Data regarding using angiotensin receptor-neprilysin inhibitor (ARNI) in patients with both heart failure with reduced ejection fraction (HFrEF) and advanced chronic kidney disease (CKD) are limited. METHODS AND RESULTS: Between January 2016 and December 2018, patients with HFrEF and adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Fu-Chih, Lin, Chia-Pin, Yu, Chun-Chen, Tung, Ying-Chang, Chu, Pao-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963957/
https://www.ncbi.nlm.nih.gov/pubmed/35360037
http://dx.doi.org/10.3389/fcvm.2022.794707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963957/
https://www.ncbi.nlm.nih.gov/pubmed/35360037
http://dx.doi.org/10.3389/fcvm.2022.794707

Ejemplares similares